![Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology](https://i1.rgstatic.net/ii/profile.image/899362599231489-1591436161724_Q512/Fabio_Gomes11.jpg)
Fabio GOMES | Clinical Research Fellow | MD MRes | The Christie NHS Foundation Trust, Manchester | Medical Oncology
![Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer](https://ecancer.org/es/journal/article/site/data/images/article/1109/can-14-1104fig1.gif)
Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials - ecancer
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients wit
![Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective - Journal of Geriatric Oncology Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective - Journal of Geriatric Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4b27ccf4-ebdd-4bef-9141-28c9051b3358/gr1.jpg)
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective - Journal of Geriatric Oncology
![PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials](https://i1.rgstatic.net/publication/344250532_Olaparib_treatment_in_older_patients_with_ovarian_cancer_need_for_'real-world'_data_beyond_clinical_trials/links/5f60aa2692851c0789679ea6/largepreview.png)
PDF) Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials
![PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper](https://i1.rgstatic.net/publication/329095838_Use_of_cyclin-dependent_kinase_46_CDK46_inhibitors_in_older_patients_with_ER-positive_HER2-negative_breast_cancer_Young_International_Society_of_Geriatric_Oncology_review_paper/links/5bf5745b4585150b2bc8ac62/largepreview.png)
PDF) Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper
![Gabor Liposits в Twitter: Gabor Liposits в Twitter:](https://pbs.twimg.com/media/DwDQ0GJWkAAGDe9.jpg)